C.R. Bard Inc. v. AngioDynamics, Inc., Appeal No. 2019-1756, -1934 (Fed. Cir. Nov. 10, 2020) -
Our Case of the Week is one of two cases decided this week in which the Federal Circuit finds that a district court jumped the...more
11/17/2020
/ Appeals ,
Appellate Courts ,
Claim Construction ,
Discovery ,
Dismissals ,
Equitable Estoppel ,
Genuine Issue of Material Fact ,
Inter Partes Review (IPR) Proceeding ,
Inventors ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Petition for Writ of Certiorari ,
Pharmaceutical Patents ,
Summary Judgment
PATENT CASE OF THE WEEK -
Dana-Farber Cancer Institute, Inc. v. Ono Pharmaceutical Co., Ltd., Appeal No. 2019-2050 (Fed. Cir. July 14, 2020) -
In this week’s Case of the Week, the Federal Circuit addressed inventorship...more
PATENT CASE OF THE WEEK -
Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC, Appeal No. 2019-1924 (Fed. Cir. May 8, 2020) -
This week’s Case of the Week features an appeal from the United States District Court for the...more
PATENT CASE OF THE WEEK -
Amgen Inc. v. Amneal Pharmaceuticals LLC, et al., Appeal Nos. 2018-2414, et al. (Fed. Cir. Jan. 7, 2020) -
In this appeal from Markman and summary judgment opinions by the district court in a...more
1/14/2020
/ Abbreviated New Drug Application (ANDA) ,
America Invents Act ,
Amgen ,
Claim Construction ,
Hatch-Waxman ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
POSITA ,
Prior Art
PATENT CASE OF THE WEEK -
Persion Pharms. LLC v. Alvogen Malta Operations Ltd., Appeal No. 2018-2361 (Fed. Cir. Dec. 27, 2019) -
In this week’s Case of the Week, the Federal Circuit affirmed a district court judgment...more
12/31/2019
/ Appeals ,
Evidence ,
Food and Drug Administration (FDA) ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Prior Art ,
Reaffirmation
PATENT CASE OF THE WEEK -
Blackbird Tech LLC v. Health in Motion LLC, Appeal No. 2018-2393 (Fed. Cir. Dec. 16, 2019) -
In this week’s Case of the Week, the Federal Circuit affirmed a fee award against prevailing...more
12/24/2019
/ Amgen v Hospira ,
Appeals ,
Claim Construction ,
Frivolous Lawsuits ,
Judgment As A Matter Of Law ,
Jury Verdicts ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Safe Harbors ,
Statutory Interpretation ,
Subject Matter Jurisdiction ,
Vacated
PATENT CASE OF THE WEEK -
HZNP Medicines LLC v. Actavis Laboratories UT, Inc., Appeal Nos. 2017-2149, et al. (Fed. Cir. Oct. 10, 2019) -
In a lengthy decision following a bench trial, the Court addressed a matter of...more
10/22/2019
/ Abbreviated New Drug Application (ANDA) ,
Failure To State A Claim ,
Hatch-Waxman ,
Inter Partes Review (IPR) Proceeding ,
Nautilus Inc. v. Biosig Instruments ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
POSITA ,
Prevailing Party ,
Remand ,
Reversal
PATENT CASE OF THE WEEK -
HZNP Medicines LLC v. Actavis Laboratories UT, Inc., Appeal Nos. 2017-2149, et al. (Fed. Cir. Oct. 10, 2019) -
In a lengthy decision following a bench trial, the Court addressed a matter of...more
10/15/2019
/ Abbreviated New Drug Application (ANDA) ,
Appeals ,
Attorney's Fees ,
Facebook ,
Hatch-Waxman ,
Indefiniteness ,
Induced Infringement ,
Inter Partes Review (IPR) Proceeding ,
Judgment on the Pleadings ,
Litigation Fees & Costs ,
Mootness ,
Motion to Dismiss ,
Nonobvious ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
POSITA ,
Prevailing Party ,
Reaffirmation
PATENT CASE OF THE WEEK -
BioDelivery Sciences Int’l, Inc. v. Aquestive Therapeutics, Inc., Appeal Nos. 2019-1643, -1644, -1645 (Fed. Cir. Aug. 29, 2019) -
Our case of the week this week focuses on Section 314(d)—the...more
9/4/2019
/ America Invents Act ,
Anticipation ,
Appeals ,
Indefiniteness ,
Intellectual Property Litigation ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Investigational New Drug Application (IND) ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Remand ,
Vacated
PATENT CASE OF THE WEEK -
Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories, FL, Inc., Appeal No. 2018-1221 (Fed. Cir. Aug. 15, 2019) -
This week’s Case of the Week focuses on issues relating to written...more
8/20/2019
/ Abbreviated New Drug Application (ANDA) ,
Claim Construction ,
Claim Limitations ,
Hatch-Waxman ,
Motion to Amend ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Section 101 ,
Written Descriptions
PATENT CASE OF THE WEEK -
Celgene Corporation v. Laura A. Peter, Appeal Nos. 2018-1167, -1168, -1169, -1171 (Fed. Cir. July 30, 2019) -
In this week’s Case of the Week, the Federal Circuit held that the retroactive...more
8/6/2019
/ Dismissals ,
Doctrine of Equivalents ,
Estoppel ,
Failure To State A Claim ,
Fifth Amendment ,
Inter Partes Reexamination ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Reversal ,
Section 101 ,
USPTO
PATENT CASE OF THE WEEK -
General Electric Co. v. United Techs. Corp., Appeal No. 2017-2497 (Fed. Cir. July 10, 2019) -
The Case of the Week focuses on standing to bring an appeal of an adverse decision by the PTAB in...more
7/16/2019
/ Administrative Procedure Act ,
Appeals ,
Article III ,
Claim Construction ,
Final Written Decisions ,
Inter Partes Review (IPR) Proceeding ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Standing ,
Vacated
PATENT CASE OF THE WEEK -
Elbit Systems Land and C4I Ltd. v. Hughes Network Systems, LLC, Appeal No. 2018-1910 (Fed. Cir. June 25, 2019) -
In this appeal from the United States District Court for the Eastern District of...more
7/2/2019
/ Appeals ,
Attorney's Fees ,
Damages ,
Dismissals ,
Doctrine of Equivalents ,
Exceptional Case ,
Expert Testimony ,
Lack of Jurisdiction ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Section 101 ,
Substantial Evidence ,
Vacated
PATENT CASE OF THE WEEK -
AVX Corporation v. Presidio Components, Inc., Appeal No. 2018-1106 (Fed. Cir. May 13, 2019) -
Following an inter partes review upholding the patentability of certain challenged claims, the...more
5/22/2019
/ Abbreviated New Drug Application (ANDA) ,
Article III ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Standing ,
USPTO
Grunenthal GMBH v. Alkem Labs., Ltd., Appeal Nos. 2017-1153, -2048, -2049, -2050 (Fed. Cir. Mar. 28, 2019) -
This week the Federal Circuit issued a rare decision concerning the utility doctrine in patent law. In general,...more
4/2/2019
/ Computer-Related Inventions ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Section 101 ,
Section 102 ,
Section 103
PATENT CASE OF THE WEEK -
Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC, Appeal No. 2017-2508 (Fed. Cir. Feb. 6, 2019)
In an appeal from an order of the United States District Court for the District of...more
2/12/2019
/ Appeals ,
Article III ,
Claim Construction ,
Google ,
Internet Service Providers (ISPs) ,
Mootness ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Section 101 ,
Venue
PATENT CASE OF THE WEEK -
Duncan Parking Techs., Inc. v. IPS Group, Inc. and IPS Group, Inc. v. Duncan Solutions, Inc. et al., Appeal Nos. 2018-1205, -1360 (Fed. Cir. January 31, 2019) -
The Court this week provided a...more
2/5/2019
/ Appeals ,
Doctrine of Equivalents ,
Final Written Decisions ,
Intellectual Property Litigation ,
Inter Partes Review (IPR) Proceeding ,
Inventors ,
Joint Inventors ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Reversal ,
Summary Judgment ,
USPTO ,
Vacated
PATENT CASE OF THE WEEK -
Data Engine Technologies, LLC v. Google LLC, Appeal No. 2017-1135 (Fed. Cir. Oct. 9, 2018) -
In one of two Section 101 cases this week, the Federal Circuit affirmed-in-part, reversed-in-part, and...more
10/16/2018
/ Abstract Ideas ,
Appeals ,
Inter Partes Review (IPR) Proceeding ,
Judgment on the Pleadings ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Reversal ,
Section 101 ,
Summary Judgment
PATENT CASE OF THE WEEK -
Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc., Appeal Nos. 2017-2078, -2134 (Fed. Cir. Sept. 10, 2018)
The Federal Circuit affirmed the district court’s ruling following a bench trial,...more
9/18/2018
/ Bench Trial ,
De Novo Standard of Review ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Nonobvious ,
Obviousness ,
Patent Applications ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Preponderance of the Evidence ,
Printed Publications ,
Prior Art
St. Regis Mohawk Tribe v. Mylan Pharmaceuticals Inc., Appeal No. 2018-1638, -1639, -1640, -1641, -1642, -1643 (Fed. Cir. July 20, 2018} -
In a groundbreaking decision issued on Friday, the Federal Circuit held that tribal...more
7/24/2018
/ Abstract Ideas ,
Appeals ,
Generic Drugs ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Remand ,
Sovereign Immunity ,
Tribal Governments ,
USPTO ,
Vacated
PATENT CASE OF THE WEEK -
Polara Engineering Inc. v. Campbell Company, Appeal Nos. 2017-1974, -2033 (Fed. Cir. July 10, 2018)
In this wide-ranging opinion, the Court provided a rare and lengthy opinion on the public use...more
7/18/2018
/ Claim Construction ,
En Banc Review ,
Enhanced Damages ,
Experimental Use Exception ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Public Use ,
Trade Secrets
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products IP Ltd., Appeal Nos. 2016-2616, -2656 (Fed. Cir. May 16, 2018) -
In an appeal from a inter partes review, the Federal Circuit reviewed a PTAB obviousness...more
5/22/2018
/ Burden of Proof ,
Claim Construction ,
Claim Limitations ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Personal Jurisdiction ,
Pharmaceutical Patents ,
Prior Art ,
Section 101 ,
Venue ,
Writ of Mandamus
In an ANDA applicant’s appeal from a bench trial judgment of validity and infringement, the Court affirmed the district court’s judgment on all counts. The case presented unusual procedural circumstances in a Hatch-Waxman...more
4/17/2018
/ Abbreviated New Drug Application (ANDA) ,
Failure To State A Claim ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Hatch-Waxman ,
Induced Infringement ,
Off-Label Use ,
Orange Book ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patent-in-Suit ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs
Berkheimer v. HP Inc., Appeal No. 2017-1437 (Fed. Cir. Feb. 8, 2018) -
In Berkheimer v. HP Inc., the Federal Circuit reviewed the District Court’s summary judgment finding that certain claims of a patent were invalid as...more
2/13/2018
/ AbbVie ,
Abstract Ideas ,
Antitrust Violations ,
Appeals ,
CLS Bank v Alice Corp ,
Contract Disputes ,
Contract Interpretation ,
Declaratory Judgments ,
Discovery Violations ,
Expert Testimony ,
Fraud ,
Hatch-Waxman ,
Hospira ,
Indefiniteness ,
Inter Partes Review (IPR) Proceeding ,
Inventions ,
Jurisdiction ,
License Agreements ,
Licensees ,
Merck ,
Misrepresentation ,
Motivation to Combine ,
Motor Vehicles ,
Nonobvious ,
Obviousness ,
On-Sale Bar ,
Patent Applications ,
Patent Examinations ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patent Term Adjustment ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Preliminary Injunctions ,
Prior Art ,
Sales & Distribution Agreements ,
Section 101 ,
Substantial Evidence ,
Summary Judgment ,
Walker Process Claims ,
Wrongful Termination